Research Article: Analysis of Risk Factors for Revitrectomy in Eyes with Diabetic Vitreous Hemorrhage
Introduction:
Diabetic retinopathy (DR), a microvascular complication of diabetes, is the leading cause of blindness among working-age adults. Pars plana vitrectomy (PPV) is widely used to treat proliferative DR (PDR) complications, including non-clearing vitreous hemorrhage (NCVH), proliferative fibrovascular membrane, and tractional retinal detachment (TRD). Although the use of anti-vascular endothelial growth factor (VEGF) drugs and microinvasive vitrectomy systems (MIVS) has significantly improved the efficacy and safety of…
Read more